FDA Brief

Warning letters Drugs

FDA warning letter to

Noticias Mexico Hoy Grupo Multimedia, S.A. de C.V.

High riskIssued Jun 27, 2022Posted Jul 12, 2022Center for Drug Evaluation and Research | CDER

Noticias Mexico Hoy Grupo Multimedia's hand sanitizer labeled as ethanol was found to contain methanol.

What happened

FDA laboratory testing of a batch of Medical MARY CLEAN HAND Sanitizers detained at the U.S. border after an attempted import found an average of 0.34% ethanol and 78% methanol, although the label declared 75% ethanol. FDA said the product is adulterated, is an unapproved new drug, and is misbranded, and noted it placed the firm's drugs on Import Alert 66-78.

What FDA found

  1. The hand sanitizer's labeled active ingredient, ethanol, was substituted wholly or partly with methanol, a dangerous chemical.

    section 501(d)(2) of the FD&C Act, 21 U.S.C. 351(d)(2)
  2. The substitution showed that quality assurance at the facility was not working under CGMP requirements.

    section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer was an unapproved new drug and did not meet the conditions for marketing without an approved application.

    sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d)
  4. The label was false or misleading because it declared 75% ethanol but the product contained far less ethanol and undeclared methanol.

    section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  5. The label failed to list methanol as an ingredient.

    section 502(e)(1)(A) of the FD&C Act, 21 U.S.C. 352(e)(1)(A)
  6. The label lacked a U.S. address or telephone number for reporting serious adverse events.

    section 502(x) of the FD&C Act, 21 U.S.C. 352(x)

What FDA wants

FDA asks the firm to respond in writing within 15 working days with a detailed investigation, raw material and supplier lists, a list and reconciliation of U.S.-shipped batches, and complete batch records. FDA also recommends a qualified CGMP consultant if the firm intends to resume manufacturing drugs for the U.S. market.

Who should pay attention

  • distributors and importers of hand sanitizers
  • brands that use this contract manufacturer
  • retailers selling Medical MARY hand sanitizer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk